CHAMPIONS ONCOLOGY, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.30% for the 12-month period ending 2013-04-30, per its 10-K filed 2014-07-28.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2014-07-28
- CHAMPIONS ONCOLOGY, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 0.30%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2013-04-30 | 0.30% 10-K · filed 2014-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |